Role of the circulatory interleukin-6 in the pathogenesis of gliomas: A systematic review
Manish Singh, Alok Raghav, Kirti Amresh Gautam
Abstract
BACKGROUND: Glioma is the most common primary tumor in the brain originating from glial cells. In spite of extensive research, the overall survival rate is not enhanced. A number of published articles observed differentially circulating levels of cytokines in glioma. Interleukin-6 (IL-6) protein coded by IL-6 gene is regulated by the immune system and it has been found to have a significant role in progression and apoptosis resistance of glioma. AIM: To review the role of circulatory IL-6 in the development and progression of glioma and its utility as a biomarker. METHODS: ) tool to search the potential studies and performed data extraction from selected studies. RESULTS: The published results were inconsistent; however, most studies showed a significantly higher IL-6 level in glioma cases as compared to controls. Comparative IL-6 level among the different grades of glioma showed a higher level with low-grade gliomas and lower level with high-grade gliomas. CONCLUSION: IL-6 level significantly differed between cases and controls, and among different cancer stages, which shows its potential as a diagnostic and prognostic marker.